Analysis of the UK Government’s 10-Year Drugs Strategy—a resource for practitioners and policymakers
Journal of Public Health · 2023
DOI: 10.1093/pubmed/fdac114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Public Health, 2023. Verfasst von Adam Holland und 20 weiteren Autor:innen. Beteiligte Einrichtung: Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK. Hauptthemen laut MEDLINE: Public Policy, Substance-Related Disorders. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
In 2021, during a drug-related death crisis in the UK, the Government published its ten-year drugs strategy. This article, written in collaboration with the Faculty of Public Health and the Association of Directors of Public Health, assesses whether this Strategy is evidence-based and consistent with international calls to promote public health approaches to drugs, which put ‘people, health and human rights at the centre’. Elements of the Strategy are welcome, including the promise of significant funding for drug treatment services, the effects of which will depend on how it is utilized by services and local commissioners and whether it is sustained. However, unevidenced and harmful measures to deter drug use by means of punishment continue to be promoted, which will have deleterious impacts on people who use drugs. An effective public health approach to drugs should tackle population-level risk factors, which may predispose to harmful patterns of drug use, including adverse childhood experiences and socioeconomic deprivation, and institute evidence-based measures to mitigate drug-related harm. This would likely be more effective, and just, than the continuation of policies rooted in enforcement. A more dramatic re-orientation of UK drug policy than that offered by the Strategy is overdue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.
- School of Social Policy, Sociology and Social Research, University of Kent, Canterbury, CT2 7NZ.
- Department of Public Health, Environments and Society, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK.
- Public Health Specialty Registrar, Department of Epidemiology and Public Health, University College London, London, WC1E 6BT, UK.
- Public Health Institute, Liverpool John Moores University, Liverpool, L3 5UX, UK.
- Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, NE1 7RU, UK.
ORCID-Profile: Adam Holland, Dan Lewer, Daniel Stewart, James Nicholls
Förderung
- Medical Research Council
Zitieren
APA
Holland, A., Stevens, A., Harris, M., Lewer, D., Sumnall, H., Stewart, D., Gilvarry, E., Wiseman, A., Howkins, J., McManus, J., Shorter, G. W., Nicholls, J., Scott, J., Thomas, K., Reid, L., Day, E., Horsley, J., Measham, F., Rae, M., …, & Hickman, M. (2023). Analysis of the UK Government’s 10-Year Drugs Strategy—a resource for practitioners and policymakers. Journal of Public Health. https://doi.org/10.1093/pubmed/fdac114
Vancouver
Holland A, Stevens A, Harris M, Lewer D, Sumnall H, Stewart D, et al. Analysis of the UK Government’s 10-Year Drugs Strategy—a resource for practitioners and policymakers. Journal of Public Health. 2023. doi:10.1093/pubmed/fdac114
BibTeX
@article{Holland2023,
author = {Holland, Adam and Stevens, Alex and Harris, Magdalena and Lewer, Dan and Sumnall, Harry and Stewart, Daniel and Gilvarry, Eilish and Wiseman, Alice and Howkins, Joshua and McManus, Jim and Shorter, Gillian W and Nicholls, James and Scott, Jenny and Thomas, Kyla and Reid, Leila and Day, Edward and Horsley, Jason and Measham, Fiona and Rae, Maggie and Fenton, Kevin and Hickman, Matthew},
title = {Analysis of the UK Government’s 10-Year Drugs Strategy—a resource for practitioners and policymakers},
journal = {Journal of Public Health},
year = {2023},
doi = {10.1093/pubmed/fdac114}
}
EUVIMED